SCHEMBL443027

SCHEMBL443027

CCc1cc(CN)on1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4302835 0.98 NOTUM (0.43)
SCHEMBL9285410 0.84
SCHEMBL459183 0.83 PPARA (0.43)
SCHEMBL8605187 0.79 PPARA (0.57)
SCHEMBL11454209 0.78
SCHEMBL2038427 0.78
SCHEMBL14394814 0.78
SCHEMBL10154648 0.78 PPARA (0.45)
SCHEMBL2121795 0.78
SCHEMBL9629469 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729105-B2 Heteroarylmethyl amides HOFFMANN LA-ROCHE INC. (US) 2014-05-20 US claimed
EP-2613785-A1 HETEROARYLMETHYL AMIDES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-17 EP claimed
WO-2012032018-A1 HETEROARYLMETHYL AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-15 WO claimed
US-20250382304-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS NUVALENT INC (US) 2025-12-18 US disclosed
US-12275742-B2 Heteroaromatic macrocyclic ether chemotherapeutic agents NUVALENT, INC. (US) 2025-04-15 US disclosed
US-11667649-B2 Heteroaromatic macrocyclic ether chemotherapeutic agents NUVALENT, INC. (US) 2023-06-06 US disclosed
CN-115916196-A Heteroaromatic macrocyclic ether chemotherapeutic agents 纽威伦特公司 2023-04-04 CN disclosed
EP-4146205-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS Nuvalent, Inc. (US) 2023-03-15 EP disclosed
US-20230076627-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS NUVALENT, INC. 2023-03-09 US disclosed
US-20220340586-A9 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS NUVALENT, INC. 2022-10-27 US disclosed
US-20220098212-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS NUVALENT INC (US) 2022-03-31 US disclosed
CN-1809573-A Tricyclic indole derivatives and their use in the treatment of alzheimer's disease GLAXO GROUP LTD (GB) 2006-07-26 CN disclosed
CN-1735592-A Hydroxyethylamine derivatives for the treatment of alzheimer's disease GLAXO GROUP LTD (GB) 2006-02-15 CN disclosed
US-20060025459-A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease GLAXO GROUP LIMITED (GB) 2006-02-02 US disclosed
EP-1567488-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2005-08-31 EP disclosed
WO-2004050619-A1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2004-06-17 WO disclosed
US-5256682-A Anxiolytic agents SCHERING AKTIENGESELLSCHAFT (DE) 1993-10-26 US disclosed
EP-0533878-A1 ISOXAZOLYL IMIDAZOLE DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR USE IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 1993-03-31 EP disclosed
CN-1066848-A Different  azoles base imdazole derivatives, its production method and the purposes in medicament thereof SCHERING AG (DE) 1992-12-09 CN disclosed
WO-1992018500-A1 ISOXAZOLYL IMIDAZOLE DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR USE IN MEDICAMENTS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1992-10-29 WO disclosed